At SP $0.033, Mcap of $30.64mln & est cash of $2.5mln without debt, CDY's EV is $28.14mln
On the verge of multiple international Advangen rollouts, an additional $10mln in the bank ($12.5mln Cash v $2.5mln cash) should translate to a large increase in EV as well as mcap)
Lets assume the entire amount were directed to Advangen and it's US rollout and not the more valuable Mk SBU's.
$10mln - est $1mln (Rollout costs) leaves 9mln for COGs.
At 70%+ margin, this equates to 30mln in expected sales (9mln / (1 - 70%)) or an 21mln increase in cash.
$28.14mln EV + 2.5mln cash already on hand + 21mln increase = $51.64mln Mcap
This would equate to an Mcap 23.5 million above where it is today.
With 1.227mln FPO on issue, using this logic CDYO conversion would contribute a $0.009 increase in SP.
This is just an example calc. of my weighing up ROA against dilution. It highlights that a CDYO conversion is more positive for the CDY share price then lapse & the additional $10mln in the kitty should be factored into the SP as conversion date approaches.
- Forums
- ASX - By Stock
- AN1
- Broker data
Broker data, page-42
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.229M |
Open | High | Low | Value | Volume |
0.6¢ | 0.7¢ | 0.6¢ | $94 | 14.91K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 144978 | 0.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.8¢ | 224908 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 144978 | 0.007 |
4 | 765639 | 0.006 |
2 | 420000 | 0.005 |
3 | 825000 | 0.004 |
1 | 600000 | 0.003 |
Price($) | Vol. | No. |
---|---|---|
0.008 | 224908 | 3 |
0.009 | 280000 | 1 |
0.010 | 157763 | 1 |
0.013 | 750000 | 1 |
0.015 | 340000 | 2 |
Last trade - 10.23am 13/08/2024 (20 minute delay) ? |
Featured News
AN1 (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online